SEP 22, 2014 12:00 AM PDT

NIH Funds Potential Cure for Ebola Explored at Ben-Gurion University

WRITTEN BY: Ilene Schneider
Sixty percent of those infected in Africa die within eight days to three weeks after contracting the Ebola virus. But some people survive and they may hold the key to a cure being developed by researchers from Ben-Gurion University of the Negev (BGU).

Dr. Leslie Lobel, a professor at BGU's Center for Emerging Disease, Tropical Diseases and AIDS has been working with the disease in Africa for more than a decade. Currently, working with survivors, Lobel has been studying the immune response to these viruses and is hoping to isolate the antibodies to develop an effective treatment to prevent future outbreaks.

In a paper written by Dr. Lobel and others in Infectious Diseases, the authors explained that they performed a serological study of the humoral immune response against the individual viral proteins of Sudan ebolavirus (Gulu) in human survivors to better understand humoral immunity following Ebolavirus infection. They used an ELISA assay specific for full-length recombinant viral proteins NP, VP30, VP40 and GP (GP lacking the transmembrane domain) of Sudan ebolavirus (Gulu) and a plaque reduction neutralization test. The researchers screened and analyzed serum samples from human survivors, collected up to ten years following recovery.

According to Dr. Lobel, the results demonstrate that samples obtained ten years following infection contain virus-specific antibodies and can neutralize the virus. They concluded that neutralization correlates well with immunoreactivity against the viral proteins NP, VP30 and GP and that sera from individuals who died, or with no documented infection but immunoreactive to Ebolavirus, did not neutralize. The researchers said that their work provides insight into the duration, profile of immunoreactivity, and neutralization capacity of the humoral immune response in Ebolavirus survivors.

Using blood samples from survivors in the field, Lobel's BGU lab team "isolates and produces molecules in the lab that are naturally produced by the immune system in survivors," and they are attached to the Ebola virus to inhibit infection. These are the antibodies that the body produces naturally as part of the immune system's response to the pathogens. One of only a handful of studies currently being conducted around the world, it could lead to the first effective treatment for Ebola in as soon as five years. This research is being funded by the US National Institutes of Health and other backers. Following initial testing in animal models, if successful, the potential treatment can be tested in humans.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
FEB 10, 2020
Immunology
FEB 10, 2020
How Cancer Evades the Immune System Time and Time Again
Scientists discovered a new mechanism by which cancer cells evade the immune system to further their own agenda: invade, ...
APR 02, 2020
Immunology
APR 02, 2020
Potential New COVID-19 Vaccine is Delivered by Patch
The coronavirus pandemic caused by SARS-CoV-2 is demanding the world's immediate attention.
APR 07, 2020
Immunology
APR 07, 2020
Too Much Salt Is Bad for the Immune System
Excessive salt intake is associated with health consequences for more than just cardiovascular status; the immune system ...
APR 21, 2020
Clinical & Molecular DX
APR 21, 2020
New Diagnostic FET-based Biosensor Enables Rapid Detection of SARS-CoV-2
The coronavirus disease 2019 (COVID-19) pandemic continues to be at the forefront of the World’s attention. COVID- ...
APR 26, 2020
Microbiology
APR 26, 2020
Researchers Design A Polio Vaccine That Won't Cause Polio
Sustained, intense efforts to vaccinate were getting the world very close to eradicating polio, but the vaccine itself o ...
MAY 02, 2020
Immunology
MAY 02, 2020
Cellular "Cleaning Crews" Get Busy During Spinal Cord Injury
  Nerve cells transmit and receive information traversing the human body in the form of electrical impulses. These ...
Loading Comments...